Baxter Total Assets 2006-2020 | BAX

Baxter total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Baxter total assets for the quarter ending June 30, 2020 were $19.465B, a 10.95% increase year-over-year.
  • Baxter total assets for 2019 were $18.193B, a 15.73% increase from 2018.
  • Baxter total assets for 2018 were $15.72B, a 8.13% decline from 2017.
  • Baxter total assets for 2017 were $17.111B, a 10.07% increase from 2016.
Baxter Annual Total Assets
(Millions of US $)
2019 $18,193
2018 $15,720
2017 $17,111
2016 $15,546
2015 $20,962
2014 $26,138
2013 $25,224
2012 $20,390
2011 $19,073
2010 $17,489
2009 $17,354
2008 $15,405
2007 $15,294
2006 $14,686
2005 $12,727
Baxter Quarterly Total Assets
(Millions of US $)
2020-06-30 $19,465
2020-03-31 $19,075
2019-12-31 $18,193
2019-09-30 $17,299
2019-06-30 $17,544
2019-03-31 $16,350
2018-12-31 $15,720
2018-09-30 $16,847
2018-06-30 $16,578
2018-03-31 $16,890
2017-12-31 $17,111
2017-09-30 $17,541
2017-06-30 $16,963
2017-03-31 $15,659
2016-12-31 $15,546
2016-09-30 $15,795
2016-06-30 $15,982
2016-03-31 $17,350
2015-12-31 $20,962
2015-09-30 $20,172
2015-06-30 $30,015
2015-03-31 $24,861
2014-12-31 $26,138
2014-09-30 $25,563
2014-06-30 $25,629
2014-03-31 $25,261
2013-12-31 $25,224
2013-09-30 $25,250
2013-06-30 $23,751
2013-03-31 $20,318
2012-12-31 $20,390
2012-09-30 $19,825
2012-06-30 $18,446
2012-03-31 $18,784
2011-12-31 $19,073
2011-09-30 $17,843
2011-06-30 $17,741
2011-03-31 $17,413
2010-12-31 $17,489
2010-09-30 $17,563
2010-06-30 $16,487
2010-03-31 $17,166
2009-12-31 $17,354
2009-09-30 $16,954
2009-06-30 $15,743
2009-03-31 $14,953
2008-12-31 $15,405
2008-09-30 $15,209
2008-06-30 $15,470
2008-03-31 $14,972
2007-12-31 $15,294
2007-09-30 $14,147
2007-06-30 $14,659
2007-03-31 $14,483
2006-12-31 $14,686
2006-09-30 $13,931
2006-06-30 $13,007
2006-03-31 $12,780
2005-12-31 $12,727
2005-09-30 $13,783
2005-06-30 $13,626
2005-03-31 $13,808
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $41.050B $11.362B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $190.845B 34.22
Medtronic (MDT) Ireland $149.772B 28.21
Stryker (SYK) United States $83.174B 32.25
Boston Scientific (BSX) United States $53.178B 30.72
Lonza Group Ag (LZAGY) Switzerland $47.347B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $30.025B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.548B 24.52
Terumo (TRUMY) Japan $28.364B 36.26
ResMed (RMD) United States $26.523B 38.45
Sunny Optical Technology (SNPTF) China $17.297B 0.00
Bio-Rad Laboratories (BIO) United States $17.264B 78.08
Smith & Nephew SNATS (SNN) United Kingdom $16.848B 0.00
Insulet (PODD) United States $16.373B 692.75
DiaSorin S.p.A (DSRLF) Italy $12.588B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
Quidel (QDEL) United States $10.412B 55.16
GN STORE NORD (GNNDY) Denmark $9.996B 50.95
William Demant Holdings (WILYY) Denmark $8.193B 0.00
Canopy Growth (CGC) Canada $7.335B 0.00
Perrigo (PRGO) Ireland $6.226B 10.68
Hill-Rom Holdings (HRC) United States $6.153B 15.27
Haemonetics (HAE) United States $5.422B 36.13
Envista Holdings (NVST) United States $4.406B 30.04
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.095B 0.00
ICU Medical (ICUI) United States $4.037B 30.80
Abcam (ABCZY) $3.853B 0.00
Neogen (NEOG) United States $3.834B 62.86
National Vision Holdings (EYE) United States $3.469B 539.13
TG Therapeutics (TGTX) United States $3.420B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.949B 0.00
NuVasive (NUVA) United States $2.684B 37.40
Agios Pharmaceuticals (AGIO) United States $2.629B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.406B 0.00
AtriCure (ATRC) United States $1.706B 0.00
Owens & Minor (OMI) United States $1.627B 36.44
Cardiovascular Systems (CSII) United States $1.568B 0.00
NanoString Technologies (NSTG) United States $1.372B 0.00
InMode (INMD) Israel $1.327B 33.46
Aphria (APHA) Canada $1.314B 0.00
MacroGenics (MGNX) United States $1.195B 0.00
Quanterix (QTRX) United States $1.154B 0.00
OraSure Technologies (OSUR) United States $1.067B 0.00
Cerus (CERS) United States $1.054B 0.00
BioLife Solutions (BLFS) United States $0.929B 483.67
PetIQ (PETQ) United States $0.871B 24.98
Lantheus Holdings (LNTH) United States $0.864B 11.97
Vapotherm (VAPO) United States $0.814B 0.00
Meridian Bioscience (VIVO) United States $0.786B 18.15
Phibro Animal Health (PAHC) United States $0.739B 16.93
LeMaitre Vascular (LMAT) United States $0.664B 40.52
Eagle Pharmaceuticals (EGRX) United States $0.637B 90.04
Omeros (OMER) United States $0.581B 0.00
Surmodics (SRDX) United States $0.557B 61.08
Varex Imaging (VREX) United States $0.555B 24.05
Aurora Cannabis (ACB) Canada $0.540B 0.00
Zynex (ZYXI) United States $0.502B 43.85
Surface Oncology (SURF) United States $0.382B 0.00
Viemed Healthcare (VMD) United States $0.372B 13.22
HEXO (HEXO) $0.372B 0.00
Cytosorbents (CTSO) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.309B 26.54
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Organigram Holdings (OGI) Canada $0.245B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.216B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Wound Management Technologies (SMTI) United States $0.191B 0.00
Exagen (XGN) United States $0.185B 0.00
Chimerix (CMRX) United States $0.175B 0.00
Female Health (VERU) United States $0.172B 0.00
Fonar (FONR) United States $0.138B 18.29
Liberty Health Sciences (LHSIF) United States $0.130B 0.00
Evolus (EOLS) United States $0.118B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
Capricor Therapeutics (CAPR) United States $0.088B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.076B 0.00
United-Guardian (UG) United States $0.068B 15.31
Rockwell Medical (RMTI) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 12.23
Nephros (NEPH) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.060B 0.00
MTech Acquisition (KERN) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.024B 0.00
FSD PHARMA INC (HUGE) Canada $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.006B 0.00